$0.966
+0.113 (+11.68%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TVRD Prediction & Forecast by Similar Chart Analysis
Alphio's TVRD stock price prediction model matches the current Tvardi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.96 (-0.47%). The 1-week path is $0.96 (-0.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Tvardi Therapeutics Inc Stock?
Tvardi Therapeutics is a good buy right now, trading at $0.9655 with a recent RSI of 65.93 suggesting strong momentum. Analysts have set a price target of $14, which represents a potential upside of over 1,400% from the current price. The recent 5-day price change of +21.78% indicates positive short-term momentum, while the projected trajectory suggests a potential increase of 151.76% based on historical patterns. However, the company faces risks with a high net income loss of $6.8 million in Q1 2026, which could impact investor confidence.
TVRD stock price ended at $0.97 on Friday, after rising +11.68%
Tvardi Therapeutics Inc (TVRD) last closed at $0.9655, gaining +11.68%. These facts feed the 1-day and 1-week TVRD price prediction above.
Forecast Drivers
Tvardi Therapeutics Inc (TVRD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TVRD, ranked by similarity.
Seasonality analysis for TVRD
Historically the probability of a positive November return for TVRD is 0.00%. May offers the highest probability of a positive month at 50.79%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TVRD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $25.85 | $28.27 | $30.73 | +2828.29% |
| Dec 2026 | $23.24 | $23.44 | $27.27 | +2327.61% |
In 2026, Tvardi Therapeutics Inc (TVRD) is projected to range from $23.24 to $30.73.
Tvardi Therapeutics Inc 2026 monthly forecast
In Nov 2026, Tvardi Therapeutics Inc is projected to average $28.27, with a low of $25.85 and high of $30.73.
In Dec 2026, Tvardi Therapeutics Inc is projected to average $23.44, with a low of $23.24 and high of $27.27.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.